A Randomised Pilot Study to Evaluate the Effect(s) of Casodex 150 mg and Zoladex 3.6 mg on Pathological and Genomic Tumour Markers in Subjects Undergoing Radical Prostatectomy for Localised Prostate Carcinoma
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacodynamics
Most Recent Events
- 01 Jul 2012 Results published in the Journal of Pathology.
- 05 Jun 2009 New trial record.